1. Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis. Issue 3 (4th July 2016) Authors: Renna, S.; Orlando, E.; Macaluso, F. S.; Maida, M.; Affronti, M.; Giunta, M.; Sapienza, C.; Rizzuto, G.; Orlando, R.; Dimarco, M.; Cottone, M.; Orlando, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 3(2016) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?. Issue 9 (May 2016) Authors: Madonia, S.; Orlando, E.; Stagno, B.; Cannizzaro, M.; Madonia, G.; Cottone, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 9(2016) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter: switching from one to another anti‐tumour necrosis factor alpha agent, and the risks of an overlap of exposure. Issue 9 (May 2016) Authors: Macaluso, F. S.; Criscuoli, V.; Orlando, E.; Rizzuto, G.; Renna, S.; Cottone, M.; Orlando, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 9(2016) Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab. Issue 7 (7th March 2018) Authors: Macaluso, F. S.; Orlando, R.; Renna, S.; Sapienza, C.; Ventimiglia, M.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 7(2018) Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020) Authors: Macaluso, F.S.; Ventimiglia, M.; Fries, W.; Viola, A.; Cappello, M.; Scrivo, B.; Magnano, A.; Pluchino, D.; Camilleri, S.; Garufi, S.; Di Mitri, R.; Mocciaro, F.; Magrì, G.; Ferracane, C.; Citrano, M.; Graziano, F.; Bertolami, C.; Renna, S.; Orlando, R.; Rizzuto, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.02.8 A PROSPECTIVE "REAL LIFE" STUDY ON ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS: RESULTS FROM A LONG TERM FOLLOW-UP. (24th February 2016) Authors: Orlando, A.; Renna, S.; Cappello, M.; Di Mitri, R.; Mocciaro, F.; Mazza, M.; Giunta, M.; Mendolaro, M.; Craxì, A.; Cottone, M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety. (15th March 2017) Authors: Orlando, A.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, A.; Carroccio, A.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Magazzù, G.; Citrano, M.; Accomando, S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience. (15th March 2017) Authors: Macaluso, F.S.; Sapienza, C.; Ventimiglia, M.; Renna, S.; Rizzuto, G.; Orlando, R.; Affronti, M.; Orlando, E.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants. (15th March 2017) Authors: Macaluso, F.S.; Maida, M.; Renna, S.; Orlando, E.; Affronti, M.; Sapienza, C.; Dimarco, M.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.09.1 LUPUS-LIKE REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ANTI-TNFs ARE RARE BUT INSIDIOUS ADVERSE EVENTS: DATA FROM A LARGE SINGLE-CENTER COHORT. (25th March 2019) Authors: Macaluso, F.S.; Sapienza, C.; Ventimiglia, M.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗